CCNA Team 4: Early Synaptic Changes and Metabolomics

“We’re looking at early synaptic changes in the brain in Alzheimer’s disease. These changes may lead to the discovery of new targets for treatment and new biomarkers for early diagnosis. We’re developing novel models to study the disease, new ways of imaging those models, and looking at the effects of inflammation, amyloid accumulation, and altered metabolism on neuronal cell death.”